Newsbenzinga
FDA Approves Gilead's New Single Tablet HIV Regimen
· Published
Article summary
The FDA approved Gilead Sciences' Bixlenvo, a new once-daily single tablet regimen for virologically suppressed adults treating HIV.
An excerpt from the original article.
Comments —
Loading comments…